Resultados da pesquisa - C N Paramasivan
- A mostrar 1 - 11 resultados de 11
-
1
Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repe... Por R Sahadevan, Sujatha Narayanan, C N Paramasivan, R Prabhakar, Narayanan Parameswaran
Publicado em 1995Artigo -
2
-
3
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis Por David Herbert, C N Paramasivan, P Venkatesan, G Kubendiran, R Prabhakar, D A Mitchison
Publicado em 1996Artigo -
4
Requirement of the<i>mymA</i>Operon for Appropriate Cell Wall Ultrastructure and Persistence of<i>Mycobacterium tuberculosis</i>in the Spleens of Guinea Pigs Por Amit Singh, Radhika Gupta, Ram A. Vishwakarma, P R Narayanan, C N Paramasivan, V. D. Ramanathan, Anil K. Tyagi
Publicado em 2005Artigo -
5
-
6
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs Por F A Sirgel, P. R. Donald, Joseph Odhiambo, W Githui, K. C. Umapathy, C N Paramasivan, Cheuk Ming Tam, K M Kam, Charles Lam, Kath Sole, D.A. Mitchison
Publicado em 2000Artigo -
7
-
8
Disruption of <i>mptpB</i> impairs the ability of <i>Mycobacterium tuberculosis</i> to survive in guinea pigs Por Ramandeep Singh, Vivek Rao, Harshavardhan Shakila, Radhika Gupta, Aparna Khera, Neeraj Dhar, Amit Singh, Anil Koul, Yogendra Singh, M. Naseema, P R Narayanan, C N Paramasivan, V. D. Ramanathan, Akhilesh K. Tyagi
Publicado em 2003Artigo -
9
A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens Por Neeraj Raizada, Kuldeep Singh Sachdeva, Devendra Singh Chauhan, Bharti Malhotra, Kishore Reddy, Paresh Dave, Yamuna Mundade, Pranav Patel, Ranjani Ramachandran, Ram Das, Rajesh Solanki, D. F. Wares, Suvanand Sahu, Rick O’Brien, C N Paramasivan, Puneet Dewan
Publicado em 2014Artigo -
10
Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Por A Wright, Matteo Zignol, Armand Van Deun, Dennis Falzon, Sabine Ruesch Gerdes, Knut Feldman, Sven Hoffner, Francis Drobniewski, Lucía Barrera, Dick van Soolingen, Fadila Boulabhal, C N Paramasivan, Kai Man Kam, Satoshi Mitarai, Paul Nunn, Mario Raviǵlione
Publicado em 2009Revisão -
11
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India Por Kuldeep Singh Sachdeva, Neeraj Raizada, A. Sreenivas, Anna H. van’t Hoog, Susan van den Hof, Puneet Dewan, Rahul Thakur, Radha Gupta, Shubhangi Kulsange, Bhavin Vadera, Ameet Babre, Christen M. Gray, Malik Parmar, Mayank Ghedia, Ranjani Ramachandran, Umesh Alavadi, Nimalan Arinaminpathy, Claudia M. Denkinger, Catharina Boehme, C N Paramasivan
Publicado em 2015Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Pathology
Tuberculosis
Biology
Microbiology
Mycobacterium tuberculosis
Gene
Internal medicine
Isoniazid
Antibacterial agent
Antibiotics
Genetics
Rifampicin
Sputum
Anatomy
Bacteria
Biochemistry
Ciprofloxacin
Computer science
Drug resistance
Environmental health
Genotype
Mutant
Mycobacterium
Ofloxacin
Pharmacology
Strain (injury)
Ampicillin
Animal science
Antibiotic resistance